Table 3.
Variable | Odds Ratio | 95% Confidence Interval |
---|---|---|
Anemia | ||
yes (HCT < 33%) | 1.55 | 1.23 to 1.54b |
no (HCT ≥ 33%) | 1.00 | — |
Height z-score | 0.89 | 0.83 to 0.95b |
Primary diagnosis | ||
dysplasia | 0.50 | 0.34 to 0.72b |
reflux nephropathy | 1.16 | 0.80 to 1.68 |
FSGS | 0.63 | 0.40 to 0.98c |
other | 0.83 | 0.63 to 1.09 |
obstructive uropathy | 1.00 | — |
Erythropoietin use | ||
yes | 1.51 | 1.11 to 2.07c |
no | 1.00 | — |
Race | ||
African-American | 1.45 | 1.11 to 1.90b |
Hispanic | 1.26 | 0.93 to 1.69 |
other/unknown | 0.85 | 0.50 to 1.44 |
Caucasian | 1.00 | — |
Cohort year | ||
1994 to 1997 | 1.31 | 1.04 to 1.65 |
1998 to 2004 | 1.00 | — |
Albumin | 0.72 | 0.61 to 0.86b |
Factors included in the multivariate analysis include: albumin, CKD stage, primary diagnosis, cohort year, height z-score, weight z-score, parathyroid hormone, calcium, phosphorus, anemia, antihypertensive medication use, iron supplementation, growth hormone use, and erythropoietin use.
P value < 0.005;
P value < 0.05.